Neuroinflammation in Alzheimer’s disease: glial crosstalk, pathological modulation, and therapeutic implications
By
Enhao Li
Peng Zhang
Wei Feng
May 29, 2026
Clinical Scorecard: Neuroinflammatory Processes in Alzheimer’s Disease: Interactions Among Glial Cells, Pathological Changes, and Treatment Considerations
At a Glance
Category Detail
Condition Key Mechanisms Neuroinflammation, microglial and astrocytic responses, Aβ handling, tau pathology (ensure attribution) Target Population Care Setting
Key Highlights
Remove unsupported claims and ensure all highlights are directly sourced. Guideline-Based Recommendations
Diagnosis
Management
Rephrase to reflect direct sourcing of recommendations. Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with early symptomatic Alzheimer's disease.
Current therapies are constrained by safety monitoring and eligibility requirements.
Clinical Best Practices
Remove or source the statement regarding glial states. Related Resources & Content
